RCEL
AVITA Medical Announces FDA Approval of Recell Go Mini, Optimizing Treatment for Smaller Wounds
时间:2024-12-24 05:02:00 市场: 美股 综合
AVITA Medical Announces FDA 510(K) Clearance for Cohealyx, Expanding Its Addressable Market
时间:2024-12-20 06:05:00 市场: 美股 综合
AVITA Medical Inc - to Develop Clinical Data for Cohealyx in Early 2025
时间:2024-12-20 06:05:00 市场: 美股 综合
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
时间:2024-11-13 05:03:00 市场: 美股 综合
AVITA Medical Q3 Gross Margin 83.7%
时间:2024-11-08 05:03:00 市场: 美股 综合